The Relationship Between the Scope of Essential Health Benefits and Statutory Financing: An International Comparison Across Eight European Countries

International Journal of Health Policy and Management
Philip J van der WeesPatrick P T Jeurissen

Abstract

Both rising healthcare costs and the global financial crisis have fueled a search for policy tools in order to avoid unsustainable future financing of essential health benefits. The scope of essential health benefits (the range of services covered) and depth of coverage (the proportion of costs of the covered benefits that is covered publicly) are corresponding variables in determining the benefits package. We hypothesized that a more comprehensive health benefit package may increase user cost-sharing charges. We conducted a desktop research study to assess the interrelationship between the scope of covered health benefits and the height of statutory spending in a sample of 8 European countries: Belgium, England, France, Germany, the Netherlands, Scotland, Sweden, and Switzerland. We conducted a targeted literature search to identify characteristics of the healthcare systems in our sample of countries. We analyzed similarities and differences based on the dimensions of publicly financed healthcare as published by the European Observatory on Health Care Systems. We found that the scope of services is comparable and comprehensive across our sample, with only marginal differences. Cost-sharing arrangements show the most variation....Continue Reading

References

Dec 14, 1973·Science·John E Wennberg, Gittelsohn
Jan 1, 1993·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·R R BovbjergC E Carroll
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Velasco-Garrido, R Busse
Oct 9, 2004·Health Affairs·John E Wennberg
Nov 5, 2005·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·J SchreyöggR Busse
Jul 29, 2011·BMJ : British Medical Journal·Sarah Garner, Peter Littlejohns
Jan 17, 2012·Social Science & Medicine·Bo Burström
Nov 21, 2012·The Medical Journal of Australia·Adam G ElshaugCameron D Willis
Apr 2, 2013·Lancet·Marina KaranikolosMartin McKee
Aug 22, 2013·Health Economics, Policy, and Law·Peter C Smith
Sep 24, 2013·Health Policy·Ashley N CoralloTherese A Stukel
Dec 7, 2013·Journal of Health Politics, Policy and Law·Nicholas Bagley, Helen Levy
Dec 18, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Marion Devaux
Dec 17, 2014·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Daniel StrechMonika Nothacker
Jan 2, 2015·BMJ Quality & Safety·Wendy LevinsonChoosing Wisely International Working Group

Citations

Apr 2, 2020·BMC Health Services Research·Joost Johan Godert WammesEddy M M Adang
Mar 30, 2021·International Journal of Integrated Care·Marlène KaramCatherine Hudon

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.